Medicines and Healthcare products Regulatory Agency

An executive agency, also called MHRA

The National Institute for Biological Standards and Control (NIBSC) is part of the Medicines and Healthcare products Regulatory Agency.

310 requests
Make a request to this authority
Vaccines and side affects
Response by Medicines and Healthcare products Regulatory Agency to Georgios Christodoulou on .

Awaiting classification.

Dear Georgios Christodoulou   Please find attached response and relevant documents for your recent FOI request (FOI 19/459).     Kind regard...
Pharmaceutical Inspection Findings
Response by Medicines and Healthcare products Regulatory Agency to Brendan O'Connell on .

Awaiting classification.

Our Ref: FOI 19/492 Dear Brendan O'Connell RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry which we received on...
MHRA Factor IX files years 1960 to 1986 inclusive
Response by Medicines and Healthcare products Regulatory Agency to Cressida Haughton on .

Awaiting response.

Our Ref: FOI 19/485 Dear Cressida Haughton, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry which we received o...
Number Of Adverse Events Reported By Psychiatrists
Response by Medicines and Healthcare products Regulatory Agency to Daryl Brown on .

Awaiting response.

Our Ref: FOI 19/473 Dear Daryl Brown, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry which we received on 2 Oc...
Forms to be signed by GP to prescribe Thybon Henning Liothyronine
Response by Medicines and Healthcare products Regulatory Agency to helsan on .

Awaiting response.

Dear Enquirer,   Thank you for your enquiry to the Medicines and Healthcare products Regulatory Agency. This automated response confirms that we hav...
Software systems
Response by Medicines and Healthcare products Regulatory Agency to Conor McClean on .

Successful.

FOI 19/437   Dear Conor McClean,   Thank you for your email where you asked “Could I please find out what systems you have in place for the fo...
GcMAF- Cancer treatment, Lyn Thyer (Biochemist) David Noakes Prosecutions!
Response by Medicines and Healthcare products Regulatory Agency to John Banks on .

Awaiting classification.

Our Ref: FOI 19/461 Dear John Banks, RE: REQUEST UNDER THE FREEDOM OF INFORMATION ACT 2000 Thank you for your enquiry which we received on 27 S...
Medicine Brokers
Response by Medicines and Healthcare products Regulatory Agency to John Watts on .

Successful.

29th August 2019     Dear Requestor,     As requested under the Freedom of Information Act, please find enclosed the correspondence betwee...
Cannabis Prescriptions
Response by Medicines and Healthcare products Regulatory Agency to Tyrone Armatage on .

Information not held.

Dear Tyrone Armatage, Thank you for your email to the MHRA the UK Government’s regulatory body for medicines and medical devices. I am sorry we are...
Safety assessments and clinical trials of Hepatitis B vaccine for infants
Response by Medicines and Healthcare products Regulatory Agency to Ms Neethling on .

Awaiting classification.

Dear Ms Neethling Many thanks for your information request dated 13th August 2019 where you asked for further information regarding the administrati...
GcMAF cancer cure, prevented for use by the MHRA for 24 years
Response by Medicines and Healthcare products Regulatory Agency to Eileen Bartlett on .

Awaiting classification.

Dear Eileen Bartlett Please see attached MHRA's response to the above FOI request. Best regards The FOI Licensing Team MHRA 10 South Colonnade Cana...
GCMAF enquiry
Response by Medicines and Healthcare products Regulatory Agency to Marcus flynn on .

Long overdue.

FOI 18/483 Dear Marcus Flynn, Thank you for your email of 19 June 2018 where you have stated " Im writing because its come to attention of many that...
Safety studies assessing impact on infant health when administering multiple vaccines on one visit
Response by Medicines and Healthcare products Regulatory Agency to Ms Neethling on .

Awaiting classification.

Dear Ms Neethling,   Thank you for your information request dated 23rd July 2019 where you requested information on safety studies conducted to as...
Over-the-counter medicines containing codeine - label regulations
Response by Medicines and Healthcare products Regulatory Agency to Georgia Richards on .

Partially successful.

Dear Ms Richards, Thank you for your information request, dated 6 July 2019, in which you asked for contact details of the person at IQVIA from whom M...
Case data for all reported adverse events relating to specific vaccines from 2008-2019
Response by Medicines and Healthcare products Regulatory Agency to Ms Neethling on .

Successful.

Dear Enquirer,   Thank you for your enquiry to the Medicines and Healthcare products Regulatory Agency. This automated response confirms that we hav...
Approval of Transvaginal Mesh Medical Devices
Response by Medicines and Healthcare products Regulatory Agency to Julie Loxley on .

Partially successful.

MHRA reference FOI 19/300   Dear Julie Loxley   Thank you for your email dated 02 July 2019 regarding transvaginal mesh medical devices (for i...
Vaccination coverage data
Response by Medicines and Healthcare products Regulatory Agency to Ms Neethling on .

Information not held.

Dear Ms Neethling, Thank you for your email of 25 July where you have asked to be provided with "The total number of vaccines administered by year (an...
Measles statistics
Response by Medicines and Healthcare products Regulatory Agency to Sanjay Ahuja on .

Awaiting classification.

FOI 19/334 Dear Sanjay Ahuja, Thank you for your email of 23 July where you have asked "Please could you provide the following statistics. 1. The n...
Did MHRA Benefit From The Ban On Co-proxamol?
Response by Medicines and Healthcare products Regulatory Agency to James Kelly on .

Successful.

Dear Mr Kelly,   Please find attached 3 of 3 email.   Kind Regards   Customer Services Communications division Medicines and Healthcare P...
Statements issued to Channel 4's Dispatches programme
Response by Medicines and Healthcare products Regulatory Agency to Bug Me Not on .

Awaiting classification.

FOI 19/280 Dear Owen Merriman, Thank you for your information request on 17 June 2019 in which you asked for: "1. Any correspondence received from...
Levothyroxine - is it orthomolecular
Response by Medicines and Healthcare products Regulatory Agency to Linda Sanday on .

Successful.

Dear Ms Sanday, Thank you for your follow-up enquiry. The level of levothyroxine in the blood when a patient may experience unwanted side effects (...
Product Verification FMD
Response by Medicines and Healthcare products Regulatory Agency to John Watts on .

Successful.

FOI 18/511   Dear Mr Watts,   Thank you for your information request, dated 11 September 2018, where you asked for information regarding whole...
Phenergan (Promethazine Hydrocloride) for insomnia
Response by Medicines and Healthcare products Regulatory Agency to Etienne Dechamps on .

Partially successful.

Dear Etienne Dechamps,   Please find attached the final response to the above referenced FOI request.   Kind regards,   FOI Licensing Team...
Cost of medicine waste or loss as a result of poor storage conditions
Response by Medicines and Healthcare products Regulatory Agency to Mr. Michael Hobby on .

Awaiting classification.

Dear Mr. Michael Hobby,         Thank you for your further email. This is information we do not hold and we suggest you could contact the Department...
How many private cannabis prescriptions have been applied for
Response by Medicines and Healthcare products Regulatory Agency to Greg de Hoedt on .

Successful.

Dear Greg de Hoedt,   Thank you for your email of 17 June where you have asked “How many licenses for a specials medicine importation has been app...

Only requests made using WhatDoTheyKnow are shown. ?